Weekly paclitaxel followed by 24 hour infusion high-dose 5-fluorouracil and leucovorin (T-HDFL) chemotherapy for hormone-refractory prostate cancer (HRPC).

被引：0
|
作者：
Lin, CC [1 ]
Hsu, CH [1 ]
Cheng, AL [1 ]
Guan, JY [1 ]
Huang, CY [1 ]
Chen, J [1 ]
Pu, YS [1 ]
机构：
[1] Natl Taiwan Univ, Taipei 10764, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4738
引用
收藏
页码：440S / 440S
页数：1
相关论文
共 50 条
  • [1] Weekly paclitaxel, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin (weekly TP-HDFL) in patients with metastatic or recurrent esophageal cancer
    Huang, T.
    Tsai, Y.
    Lin, C.
    Cheng, A.
    Yeh, K.
    Hsu, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial
    Lin, Chia-Chi
    Hsu, Chih-Hung
    Hour, Tzyh-Chyuan
    Cheng, Ann-Lii
    Huang, Chao-Yuan
    Huang, Kuo-How
    Chen, Jun
    Pu, Yeong-Shiau
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (03) : 207 - 213
  • [3] A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers
    Yeh, KH
    Cheng, AL
    Lin, MT
    Hong, RL
    Hsu, CH
    Lin, JF
    Chang, KJ
    Lee, PH
    Chen, YC
    [J]. ANTICANCER RESEARCH, 1997, 17 (5B) : 3867 - 3871
  • [4] Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
    Yeh, KH
    Lu, YS
    Hsu, CH
    Lin, JF
    Hsu, C
    Kuo, SH
    Li, SJ
    Cheng, AL
    [J]. ONCOLOGY, 2005, 69 (01) : 88 - 95
  • [5] Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experience
    Wang, WS
    Chen, PM
    Chiou, TJ
    Liu, JH
    Lin, JK
    Lin, TC
    Chen, WS
    Jiang, JK
    Yen, CC
    Fan, FS
    Hsieh, RK
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (01) : 16 - 19
  • [6] Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion
    H. T. Arkenau
    K. Rettig
    R. Porschen
    [J]. International Journal of Colorectal Disease, 2005, 20 : 258 - 261
  • [7] Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion
    Arkenau, HT
    Rettig, K
    Porschen, R
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2005, 20 (03) : 258 - 261
  • [8] Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas
    Chen, JS
    Jan, YY
    Lin, YC
    Wang, HM
    Chang, WC
    Liau, CT
    [J]. ANTI-CANCER DRUGS, 1998, 9 (05) : 393 - 397
  • [9] Clinical benefit and response in patients with gastric cancer to weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and leucovorin (LV)
    Lin, YC
    Liu, HE
    Wang, CH
    Wang, HM
    Yang, TS
    Liau, CT
    Chen, JS
    [J]. ANTICANCER RESEARCH, 1999, 19 (6C) : 5615 - 5620
  • [10] A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer
    Lin, CC
    Hsu, CH
    Chen, J
    Tsai, TC
    Cheng, AL
    Pu, YS
    [J]. ANTICANCER RESEARCH, 2001, 21 (2B) : 1385 - 1390
12345